Dashing hopes of plasma therapy being a cure to treat coronavirus patients, the first patient to receive the experimental treatment in Uttar Pradesh died following a heart attack on Saturday.
The patient, a 58-year-old doctor, was admitted at the King George’s Medical University (KGMU) in Lucknow. The disappointing news comes after the Indian Council of Medical Research (ICMR) received approval for the second phase of the multi-centre clinical trial of plasma therapy.
Convalescent Plasma Therapy is an experimental procedure for treating COVID-19 patients. In this treatment, plasma, a blood component, from a cured patient is transfused to a critically ill coronavirus patient.